Lab-grown tumors predict treatment outcomes in landmark study
Researchers have grown tumors in the lab to accurately predict which drugs will work for people with bowel cancer—before they begin treatment.
Feb 2, 2024
0
73
Researchers have grown tumors in the lab to accurately predict which drugs will work for people with bowel cancer—before they begin treatment.
Feb 2, 2024
0
73
A multidisciplinary team of researchers that included 14 graduate students from The University of Texas at Arlington has created a new framework to provide optimal personalized treatment options for individuals with esophageal ...
Jan 31, 2024
0
0
A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs)—soft tissue tumors that are stubbornly resistant to chemotherapy and radiation—according to a laboratory study ...
Jan 31, 2024
0
59
Depending on their location, cancer cells within a three-dimensional (3D) tumor structure can have different microenvironments. Cells in the core of the tumor receive less oxygen (hypoxia) and nutrients than those in the ...
Jan 30, 2024
0
0
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center have identified a protein called UCHL1 in highly aggressive neuroendocrine carcinomas and neuroblastoma that could potentially be used as a molecular ...
Jan 29, 2024
0
28
Researchers from seven Environment for Development (EfD) centers plus the EfD Global Hub, located at the University of Gothenburg, have conducted an extensive survey on how serious people perceive COVID-19.
Jan 26, 2024
0
20
Although the incidence of cervical cancer has declined with increased screening and higher uptake of human papillomavirus (HPV) vaccination, cervical cancer remains the second highest cause of cancer mortality among women ...
Jan 25, 2024
0
0
A new research paper titled "Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis" has been published in Aging.
Jan 24, 2024
0
0
The U.S. Food and Drug Administration has told drugmakers to add a boxed warning to a type of cancer treatment called CAR-T therapy, saying the treatment itself may sometimes cause a secondary cancer.
Jan 24, 2024
0
6
Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial led by UC San Francisco researchers ...
Jan 23, 2024
0
3